News 05 Dec. 2024
Partner Dr. Alexandra G. Maier Recognized Again in Lexology Client Choice Award 2025, Mining Experts Category 2025
more
Event 23 Oct. 2024
Counsel Mohannad El Murtadi Suleiman to Speak at the 2nd Annual Africa Arbitration Day in New York
Event 18 Aug. 2023
Partner Borzu Sabahi Speaks at FDI Moot Shenzhen
News 25 Jul. 2023
Partner Eric Gilioli Ranked in Top 10 Influential Energy & Natural Resources Lawyers in Kazakhstan in Business Today
News 09 Apr. 2024
Curtis Announces New Partners and Counsels Across Offices in Spring 2024
Client Alert 28 Dec. 2023
U.S. to Impose Secondary Sanctions on Non-U.S. Banks For Financing Russia’s Defense Industry
News 28 Aug. 2024
Curtis Recognized for Excellence in Arbitration in Chambers Latin America Guide 2025
Event 22 Aug. 2023
Partner Dr. Claudia Frutos-Peterson to Speak at Arbitration and ADR Commission of the ICC Mexico
News 08 Oct. 2024
Curtis Boosts London Finance and Corporate Capability with Appointment of Partner Christopher Harrison
News 15 Aug. 2023
Legal Reader Publishes Article on Dr. Majed Alotaibi’s Arrival as Senior Counsel in Curtis’ Riyadh Office
News 24 Aug. 2023
Curtis Attorneys Quoted in CoinDesk on FTX Founder Sam Bankman-Fried’s Strategy Ahead of His Criminal Trial
Client Alert 10 Jul. 2024
EU Adopts New Restrictive Measures Against Belarus
Client Alert 26 Jun. 2024
The EU Adopts its 14th Sanctions Package Against Russia
publications
Mohannad El Murtadi Suleiman Publishes an Article on Interim Measures in the American Review of International Arbitration (ARIA)
event
Partner Juan Perla to Speak on DEI in Corporate America at Hispanic Leadership Summit
Publications July 21, 2017
The Division of Corporation Finance of the U.S. Securities and Exchange Commission (“SEC”) has expanded the availability of confidential review of draft registration statements effective July 10, 2017. The new policy seeks to foster capital formation by providing a mechanism to support new issuers’ preparation of their registration statements and flexibility in planning their offerings.
The new policy does not impact the ability of emerging growth companies (“EGCs”) to obtain confidential review of their draft registration statements under existing procedures adopted in 2011 pursuant to the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”). Confidential review will also continue to be available to certain foreign private issuers (“FPIs”), according to SEC policy in place since 2011 (and updated in 2012). An FPI will be able to seek review in accordance with the new policy, or in accordance with the existing policy covering EGCs in the event that the FPI is an EGC or the existing 2012 policy for FPIs.
Under the new policy, the SEC will confidentially review an issuer’s initial draft registration statement and related revisions for its initial public offering (“IPO”) under the Securities Act of 1933 (the “Securities Act”). The issuer must confirm in the cover letter accompanying the draft that it will, and must, publicly file its registration statement and all confidentially submitted drafts at least 15 days prior to any road show or, in the event that there will not be a road show, at least 15 days prior to the requested effective date of the registration statement.
Similarly, the SEC will confidentially review an issuer’s initial draft registration statement and related revisions for its initial registration of a class of securities under Section 12(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) (which is required to list securities on a national securities exchange). In this case, the issuer must confirm in its cover letter that it will, and must, publicly file its registration statement and all confidentially submitted drafts at least 15 days prior to the anticipated effective date of the registration statement.
The SEC will also confidentially review initial drafts of an issuer’s registration statements for follow-on offerings and securities exchange listings submitted prior to the end of the twelfth month following the effective date of the issuer’s Securities Act IPO registration statement or Exchange Act Section 12(b) registration statement. In these cases, the issuer must confirm in its cover letter that it will, and must, publicly file the registration statement and the confidentially submitted draft in time for it to be publicly available at least 48 hours prior to the requested effective date and time. Unlike the case for initial registration statements, the SEC will confidentially review only a single draft of a follow-on registration statement. Responses to the SEC’s comments on the initial confidential draft must be reflected in a public filing.
Draft registration statements submitted for confidential review should be substantially complete. However, the SEC has stated that it will not delay processing in cases where an issuer reasonably believes that omitted financial information will not be required at the time the registration statement is publicly filed.
Form ID, the form submitted by new issuers to apply for EDGAR access codes, contains a section for EGCs and FPIs to indicate that they will use the codes to submit draft registration statements and the basis of their submission. The SEC has indicated that until the SEC updates Form ID, a new issuer should indicate on Form ID that it intends to use its EDGAR access codes to submit a draft registration statement pursuant to Section 106 of the JOBS Act. The issuer should do this even if it is not an EGC.
Confidential submission of a registration statement to the SEC does not by itself protect the registration statement from disclosure under the Freedom of Information Act (“FOIA”), even if the filer were to determine not to proceed with a public filing of the registration statement. The SEC has indicated that it will keep submitted nonpublic draft registration statements confidential subject to the provisions of applicable law, and has noted that Exemption 4 of FOIA provides for an exemption for “trade secrets and commercial or financial information obtained from a person and privileged or confidential.” Issuers seeking such protection must comply with SEC Rule 83. Pursuant to Rule 83, issuers may request that information be withheld when requested under FOIA. Under Rule 83, a submitter must mark each page with “Confidential Treatment Requested by [Issuer Name]” and an identifying number and code. The words “FOIA Confidential
Treatment Request” must appear on the top of the first page of the request, and the submitter must provide contact information.
Capital Markets
Valarie A. Hing
Partner
We use cookies on our website to enhance your browsing experience, match your interests and assess our website performance. We do not share information with any third-party for marketing purposes. Please view our privacy policy to learn more about the use of cookies on our website. By continuing to browse our website, you consent to our use of cookies.